1887

Abstract

Influenza A (H1N1) viruses of swine origin were introduced into the human population in 2009 and caused a pandemic. The disease burden in the elderly was relatively low, which was attributed to the presence of cross-reacting serum antibodies in this age group, which were raised against seasonal influenza A (H1N1) viruses that circulated before 1957. It has also been described how infection with heterosubtypic influenza viruses can induce some degree of protection against infection by a novel strain of influenza virus. Here, we assess the extent of protective immunity against infection with the 2009 influenza A (H1N1) pandemic influenza virus that is afforded by infection with a seasonal influenza A (H3N2) virus in mice. Mice that experienced a primary A (H3N2) influenza virus infection displayed reduced weight loss after challenge infection and cleared the 2009 influenza A (H1N1) virus infection more rapidly. To elucidate the correlates of protection of this heterosubtypic immunity to pandemic H1N1 virus infection, adoptive transfer experiments were carried out by using selected post-infection lymphocyte populations. Virus-specific CD8 T-cells in concert with CD4 T-cells were responsible for the observed protection. These findings may not only provide an explanation for epidemiological differences in the incidence of severe pandemic H1N1 infections, they also indicate that the induction of cross-reactive virus-specific CD8 and CD4 T-cell responses may be a suitable approach for the development of universal influenza vaccines.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.033076-0
2011-10-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/10/2339.html?itemId=/content/journal/jgv/10.1099/vir.0.033076-0&mimeType=html&fmt=ahah

References

  1. Belz G. T. , Xie W. , Altman J. D. , Doherty P. C. . ( 2000; ). A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge. . J Virol 74:, 3486–3493. [CrossRef] [PubMed]
    [Google Scholar]
  2. Benton K. A. , Misplon J. A. , Lo C. Y. , Brutkiewicz R. R. , Prasad S. A. , Epstein S. L. . ( 2001; ). Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells. . J Immunol 166:, 7437–7445.[PubMed] [CrossRef]
    [Google Scholar]
  3. Bodewes R. , Kreijtz J. H. , Baas C. , Geelhoed-Mieras M. M. , de Mutsert G. , van Amerongen G. , van den Brand J. M. , Fouchier R. A. , Osterhaus A. D. , Rimmelzwaan G. F. . ( 2009; ). Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. . PLoS ONE 4:, e5538. [CrossRef] [PubMed]
    [Google Scholar]
  4. Bodewes R. , Kreijtz J. H. , Hillaire M. L. , Geelhoed-Mieras M. M. , Fouchier R. A. , Osterhaus A. D. , Rimmelzwaan G. F. . ( 2010; ). Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice. . J Gen Virol 91:, 1743–1753. [CrossRef] [PubMed]
    [Google Scholar]
  5. Bodewes R. , de Mutsert G. , van der Klis F. R. , Ventresca M. , Wilks S. , Smith D. J. , Koopmans M. , Fouchier R. A. , Osterhaus A. D. , Rimmelzwaan G. F. . ( 2011; ). Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. . Clin Vaccine Immunol 18:, 469–476. [CrossRef] [PubMed]
    [Google Scholar]
  6. Carragher D. M. , Kaminski D. A. , Moquin A. , Hartson L. , Randall T. D. . ( 2008; ). A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. . J Immunol 181:, 4168–4176.[PubMed] [CrossRef]
    [Google Scholar]
  7. Chen W. , Pang K. , Masterman K. A. , Kennedy G. , Basta S. , Dimopoulos N. , Hornung F. , Smyth M. , Bennink J. R. , Yewdell J. W. . ( 2004; ). Reversal in the immunodominance hierarchy in secondary CD8+ T cell responses to influenza A virus: roles for cross-presentation and lysis-independent immunodomination. . J Immunol 173:, 5021–5027.[PubMed] [CrossRef]
    [Google Scholar]
  8. Corti D. , Suguitan A. L. Jr , Pinna D. , Silacci C. , Fernandez-Rodriguez B. M. , Vanzetta F. , Santos C. , Luke C. J. , Torres-Velez F. J. et al. & other authors ( 2010; ). Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. . J Clin Invest 120:, 1663–1673. [CrossRef] [PubMed]
    [Google Scholar]
  9. Crowe S. R. , Turner S. J. , Miller S. C. , Roberts A. D. , Rappolo R. A. , Doherty P. C. , Ely K. H. , Woodland D. L. . ( 2003; ). Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. . J Exp Med 198:, 399–410. [CrossRef] [PubMed]
    [Google Scholar]
  10. Cui W. , Kaech S. M. . ( 2010; ). Generation of effector CD8+ T cells and their conversion to memory T cells. . Immunol Rev 236:, 151–166. [CrossRef] [PubMed]
    [Google Scholar]
  11. de Jong J. C. , Palache A. M. , Beyer W. E. , Rimmelzwaan G. F. , Boon A. C. , Osterhaus A. D. . ( 2003; ). Haemagglutination-inhibiting antibody to influenza virus. . Dev Biol (Basel) 115:, 63–73.[PubMed]
    [Google Scholar]
  12. Doherty P. C. , Biddison W. E. , Bennink J. R. , Knowles B. B. . ( 1978; ). Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. . J Exp Med 148:, 534–543. [CrossRef] [PubMed]
    [Google Scholar]
  13. Ekiert D. C. , Bhabha G. , Elsliger M. A. , Friesen R. H. , Jongeneelen M. , Throsby M. , Goudsmit J. , Wilson I. A. . ( 2009; ). Antibody recognition of a highly conserved influenza virus epitope. . Science 324:, 246–251. [CrossRef] [PubMed]
    [Google Scholar]
  14. Fan J. , Liang X. , Horton M. S. , Perry H. C. , Citron M. P. , Heidecker G. J. , Fu T. M. , Joyce J. , Przysiecki C. T. , Keller P. M. . ( 2004; ). Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. . Vaccine 22:, 2993–3003. [CrossRef] [PubMed]
    [Google Scholar]
  15. Frank A. L. , Puck J. , Hughes B. J. , Cate T. R. . ( 1980; ). Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. . J Clin Microbiol 12:, 426–432.[PubMed]
    [Google Scholar]
  16. Grebe K. M. , Yewdell J. W. , Bennink J. R. . ( 2008; ). Heterosubtypic immunity to influenza A virus: where do we stand?. Microbes Infect 10:, 1024–1029. [CrossRef] [PubMed]
    [Google Scholar]
  17. Guo H. , Santiago F. , Lambert K. , Takimoto T. , Topham D. J. . ( 2011; ). T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. . J Virol 85:, 448–455.[PubMed] [CrossRef]
    [Google Scholar]
  18. Hancock K. , Veguilla V. , Lu X. , Zhong W. , Butler E. N. , Sun H. , Liu F. , Dong L. , DeVos J. R. et al. & other authors ( 2009; ). Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. . N Engl J Med 361:, 1945–1952. [CrossRef] [PubMed]
    [Google Scholar]
  19. Health Protection Agency ( 2009; ). Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April–June 2009. . Euro Surveill 14:, 19232.
    [Google Scholar]
  20. Heinen P. P. , Rijsewijk F. A. , de Boer-Luijtze E. A. , Bianchi A. T. . ( 2002; ). Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. . J Gen Virol 83:, 1851–1859.[PubMed]
    [Google Scholar]
  21. Jameson J. , Cruz J. , Terajima M. , Ennis F. A. . ( 1999; ). Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. . J Immunol 162:, 7578–7583.[PubMed]
    [Google Scholar]
  22. Kärber G. . ( 1931; ). Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. . Naunyn Schmiedebergs Arch Pharmacol 162:, 480–483 (in German).[CrossRef]
    [Google Scholar]
  23. Kash J. C. , Qi L. , Dugan V. G. , Jagger B. W. , Hrabal R. J. , Memoli M. J. , Morens D. M. , Taubenberger J. K. . ( 2010; ). Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus. . Influenza Other Respir Viruses 4:, 121–127. [CrossRef] [PubMed]
    [Google Scholar]
  24. Kreijtz J. H. , Bodewes R. , van Amerongen G. , Kuiken T. , Fouchier R. A. , Osterhaus A. D. , Rimmelzwaan G. F. . ( 2007; ). Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. . Vaccine 25:, 612–620. [CrossRef] [PubMed]
    [Google Scholar]
  25. Kreijtz J. H. , de Mutsert G. , van Baalen C. A. , Fouchier R. A. , Osterhaus A. D. , Rimmelzwaan G. F. . ( 2008; ). Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. . J Virol 82:, 5161–5166. [CrossRef] [PubMed]
    [Google Scholar]
  26. Kreijtz J. H. , Bodewes R. , van den Brand J. M. , de Mutsert G. , Baas C. , van Amerongen G. , Fouchier R. A. , Osterhaus A. D. , Rimmelzwaan G. F. . ( 2009; ). Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. . Vaccine 27:, 4983–4989. [CrossRef] [PubMed]
    [Google Scholar]
  27. LaMere M. W. , Lam H. T. , Moquin A. , Haynes L. , Lund F. E. , Randall T. D. , Kaminski D. A. . ( 2011a; ). Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. . J Immunol 186:, 4331–4339. [CrossRef] [PubMed]
    [Google Scholar]
  28. LaMere M. W. , Moquin A. , Lee F. E. , Misra R. S. , Blair P. J. , Haynes L. , Randall T. D. , Lund F. E. , Kaminski D. A. . ( 2011b; ). Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. . J Virol 85:, 5027–5035. [CrossRef] [PubMed]
    [Google Scholar]
  29. Laurie K. L. , Carolan L. A. , Middleton D. , Lowther S. , Kelso A. , Barr I. G. . ( 2010; ). Multiple infections with seasonal influenza A virus induce cross-protective immunity against A (H1N1) pandemic influenza virus in a ferret model. . J Infect Dis 202:, 1011–1020. [CrossRef] [PubMed]
    [Google Scholar]
  30. Lee L. Y. , Ha L. A. , Simmons C. , de Jong M. D. , Chau N. V. , Schumacher R. , Peng Y. C. , McMichael A. J. , Farrar J. J. et al. & other authors ( 2008; ). Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. . J Clin Invest 118:, 3478–3490.[PubMed]
    [Google Scholar]
  31. Manicassamy B. , Medina R. A. , Hai R. , Tsibane T. , Stertz S. , Nistal-Villán E. , Palese P. , Basler C. F. , García-Sastre A. . ( 2010; ). Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. . PLoS Pathog 6:, e1000745. [CrossRef] [PubMed]
    [Google Scholar]
  32. McMichael A. J. , Gotch F. M. , Noble G. R. , Beare P. A. . ( 1983; ). Cytotoxic T-cell immunity to influenza. . N Engl J Med 309:, 13–17. [CrossRef] [PubMed]
    [Google Scholar]
  33. Medina R. A. , Manicassamy B. , Stertz S. , Seibert C. W. , Hai R. , Belshe R. B. , Frey S. E. , Basler C. F. , Palese P. , García-Sastre A. . ( 2010; ). Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. . Nat Commun 1:, 28. [CrossRef] [PubMed]
    [Google Scholar]
  34. Min J. Y. , Chen G. L. , Santos C. , Lamirande E. W. , Matsuoka Y. , Subbarao K. . ( 2010; ). Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets. . Virology 408:, 128–133. [CrossRef] [PubMed]
    [Google Scholar]
  35. Nguyen H. H. , Moldoveanu Z. , Novak M. J. , van Ginkel F. W. , Ban E. , Kiyono H. , McGhee J. R. , Mestecky J. . ( 1999; ). Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8+ cytotoxic T lymphocyte responses induced in mucosa-associated tissues. . Virology 254:, 50–60. [CrossRef] [PubMed]
    [Google Scholar]
  36. Nishiura H. , Castillo-Chavez C. , Safan M. , Chowell G. . ( 2009; ). Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. . Euro Surveill 14:, 19227.[PubMed]
    [Google Scholar]
  37. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team ( 2009; ). Emergence of a novel swine-origin influenza A (H1N1) virus in humans. . N Engl J Med 360:, 2605–2615. [CrossRef] [PubMed]
    [Google Scholar]
  38. O’Neill E. , Krauss S. L. , Riberdy J. M. , Webster R. G. , Woodland D. L. . ( 2000; ). Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice. . J Gen Virol 81:, 2689–2696.[PubMed]
    [Google Scholar]
  39. Palmer D. W. R. , Coleman M. T. , Schild G. C. . ( 1975; ). Hemagglutination inhibition test. . Advanced Laboratory Techniques for Influenza Diagnosis Immunol Ser 6:, 25–62.
    [Google Scholar]
  40. Rangel-Moreno J. , Carragher D. M. , Misra R. S. , Kusser K. , Hartson L. , Moquin A. , Lund F. E. , Randall T. D. . ( 2008; ). B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms. . J Immunol 180:, 454–463.[PubMed] [CrossRef]
    [Google Scholar]
  41. Richards K. A. , Topham D. , Chaves F. A. , Sant A. J. . ( 2010; ). Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. . J Immunol 185:, 4998–5002. [CrossRef] [PubMed]
    [Google Scholar]
  42. Rimmelzwaan G. F. , Baars M. , Claas E. C. , Osterhaus A. D. . ( 1998; ). Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro . . J Virol Methods 74:, 57–66. [CrossRef] [PubMed]
    [Google Scholar]
  43. Rimmelzwaan G. F. , Kuiken T. , van Amerongen G. , Bestebroer T. M. , Fouchier R. A. , Osterhaus A. D. . ( 2001; ). Pathogenesis of influenza A (H5N1) virus infection in a primate model. . J Virol 75:, 6687–6691. [CrossRef] [PubMed]
    [Google Scholar]
  44. Schulman J. L. , Kilbourne E. D. . ( 1965; ). Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. . J Bacteriol 89:, 170–174.[PubMed]
    [Google Scholar]
  45. Seo S. H. , Webster R. G. . ( 2001; ). Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. . J Virol 75:, 2516–2525. [CrossRef] [PubMed]
    [Google Scholar]
  46. Skountzou I. , Koutsonanos D. G. , Kim J. H. , Powers R. , Satyabhama L. , Masseoud F. , Weldon W. C. , Martin M. P. , Mittler R. S. et al. & other authors ( 2010; ). Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. . J Immunol 185:, 1642–1649. [CrossRef] [PubMed]
    [Google Scholar]
  47. Slepushkin V. A. , Katz J. M. , Black R. A. , Gamble W. C. , Rota P. A. , Cox N. J. . ( 1995; ). Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. . Vaccine 13:, 1399–1402. [CrossRef] [PubMed]
    [Google Scholar]
  48. Song J. M. , Wang B. Z. , Park K. M. , Van Rooijen N. , Quan F. S. , Kim M. C. , Jin H. T. , Pekosz A. , Compans R. W. , Kang S. M. . ( 2011; ). Influenza virus-like particles containing M2 induce broadly cross protective immunity. . PLoS ONE 6:, e14538. [CrossRef] [PubMed]
    [Google Scholar]
  49. Steel J. , Lowen A. C. , Wang T. T. , Yondola M. , Gao Q. , Haye K. , Garcia-Sastre A. , Palese P. . ( 2010; ). Influenza virus vaccine based on the conserved hemagglutinin stalk domain. . MBiol 1:, e00018-10.
    [Google Scholar]
  50. Tompkins S. M. , Zhao Z. S. , Lo C. Y. , Misplon J. A. , Liu T. , Ye Z. , Hogan R. J. , Wu Z. , Benton K. A. et al. & other authors ( 2007; ). Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. . Emerg Infect Dis 13:, 426–435. [CrossRef] [PubMed]
    [Google Scholar]
  51. Tu W. , Mao H. , Zheng J. , Liu Y. , Chiu S. S. , Qin G. , Chan P. L. , Lam K. T. , Guan J. et al. & other authors ( 2010; ). Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. . J Virol 84:, 6527–6535. [CrossRef] [PubMed]
    [Google Scholar]
  52. Wang T. T. , Tan G. S. , Hai R. , Pica N. , Ngai L. , Ekiert D. C. , Wilson I. A. , García-Sastre A. , Moran T. M. , Palese P. . ( 2010; ). Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. . Proc Natl Acad Sci U S A 107:, 18979–18984. [CrossRef] [PubMed]
    [Google Scholar]
  53. Wareing M. D. , Shea A. L. , Inglis C. A. , Dias P. B. , Sarawar S. R. . ( 2007; ). CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance. . Viral Immunol 20:, 369–378. [CrossRef] [PubMed]
    [Google Scholar]
  54. WHO ( 2009; ). Pandemic (H1N1) 2009 – update 112. http://www.who.int./csr/don/2010_08_06/en/index.html.
  55. WHO ( 2010; ). Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. http://www.who.int./csr/disease/avian_influenza/country/en/.
  56. Yap K. L. , Ada G. L. , McKenzie I. F. . ( 1978; ). Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. . Nature 273:, 238–239. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.033076-0
Loading
/content/journal/jgv/10.1099/vir.0.033076-0
Loading

Data & Media loading...

Supplements

vol. , part 10, pp. 2339–2349

Histopathologic analysis of the lungs on day 7 post-infection with influenza A virus pH1N1. Titration of pH1N1 in mice. Confirmation of cell purity by flow cytometry.

[ Single PDF file] (5.4 MB)



PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error